The number of people with susceptibility test result for rifampicin in Mauritania
Mauritania: The number of people with susceptibility test result for rifampicin was 0 in 2021. ◆ Volatile
Latest (2021)
0
World rank
142nd
of 146 countries
All-time high
0.5055
in 2018
All-time low
0
in 2019
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Mauritania, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
Mauritania recorded 0 for the number of people with susceptibility test result for rifampicin in 2021. That is the lowest value across all 5 years on record.
The figure is down 100.0% over five years.
Mauritania ranks 142nd of 146 countries on this measure, in the bottom quarter.
The number of people with susceptibility test result for rifampicin in Mauritania, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 0.2322 | — |
| 2018 | 0.5055 | +117.7% |
| 2019 | 0 | -100.0% |
| 2020 | 0 | — |
| 2021 | 0 | — |
Mauritania compared with similar countries
- Mauritania's 0 is below the median for lower middle income countries, which is 78.77. (32 countries reporting)
- Mauritania's 0 is below the median for Sub-Saharan Africa, which is 61.16. (32 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 0.2459 | 0 | 0.5055 | 3 |
| 2020s | 0 | 0 | 0 | 2 |
Countries ranked near Mauritania
- 139 Central African Republic 9.75 compare
- 140 Venezuela, Bolivarian Republic of 3.31 compare
- 141 France 1.45 compare
- 142 South Sudan 0 compare
- 142 Grenada 0 compare
- 142 Sao Tome and Principe 0 compare
- 142 Vanuatu 0 compare
More health data for Mauritania
- Un projection of annual infant deaths, annual growth rate -0.8878 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.19 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 653 deaths per 1,000 people (2090)
- Number of infants who die before age 1 1,563 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 1.77 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.077 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.77 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Mauritania?
- The number of people with susceptibility test result for rifampicin in Mauritania was 0 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Mauritania?
- The highest recorded value was 0.5055 in 2018.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Mauritania?
- The lowest recorded value was 0 in 2019.
- How does Mauritania rank for the number of people with susceptibility test result for rifampicin?
- Mauritania ranks 142nd out of 146 countries with data for 2021.
- Where does this Mauritania data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).